Literature DB >> 24517963

Renal medullary carcinoma in a white adolescent with sickle cell trait.

Paul Daher1, Ali Bourgi, Edward Riachy, Antoine Khoury, Caline Rehayem, Claude Sader-Ghorra.   

Abstract

Renal medullary carcinoma (RMC) is a rare neoplasm of the kidney that has been recently described. It is almost exclusive to young patients of African descent and associated with sickle cell hemoglobinopathy, mainly sickle cell trait and hemoglobin sickle cell disease. The prognosis of RMC is very poor because of the highly aggressive behavior of this neoplasm and its resistance to conventional chemotherapy. Metastatic disease is almost universal at the time of presentation, and the malignancy is minimally responsive to a variety of regimens and/or modalities, including surgery, radiotherapy, chemotherapy, and biological immune-modulation therapy. We report the seventh case of a left RMC occurring in a white child with sickle cell trait, but with a localization of the tumor in the left kidney, considered a nonpredominant side for this type of tumor.

Entities:  

Mesh:

Year:  2014        PMID: 24517963     DOI: 10.1097/MPH.0000000000000118

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Endometrial stromal sarcoma presenting as large bleeding left upper quadrant mass.

Authors:  Gaya Spolverato; Elizabeth Montgomery; Ihab Kamel; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2015-10       Impact factor: 7.293

Review 2.  Renal Medullary Carcinoma: Establishing Standards in Practice.

Authors:  Kathryn E Beckermann; Deva Sharma; Shruti Chaturvedi; Pavlos Msaouel; Miguel R Abboud; Yves Allory; Franck Bourdeaut; Julien Calderaro; Aguirre A de Cubas; Vimal K Derebail; Andrew L Hong; Rakhi P Naik; Gabriel G Malouf; Elizabeth A Mullen; Victor E Reuter; Charles W M Roberts; Cheryl L Walker; Christopher G Wood; Michael R DeBaun; Hendrik Van Poppel; Nizar M Tannir; W Kimryn Rathmell
Journal:  J Oncol Pract       Date:  2017-07       Impact factor: 3.840

3.  Renal Medullary Carcinoma; A Rare Entity.

Authors:  Selahattin Çalışkan; Ali Murat Gökçe; Gülistan Gümrükçü; Mine Önenerk
Journal:  Iran J Med Sci       Date:  2017-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.